Related Experiment Video
Updated: Oct 7, 2026
The bm12 Inducible Model of Systemic Lupus Erythematosus (SLE) in C57BL/6 Mice
Published on: November 1, 2015
Low-grade non-Hodgkin's lymphoma in a patient with systemic lupus erythematosus
T Robak1, E Robak, J Bartkowiak
1Department of Hematology; Medical University of Lódź, Copernicus Memorial Hospital, Poland. robaktad@psk2.am.lodz.pl
Abstract:
Coexistence of systemic lupus erythematosus (SLE) with low-grade non-Hodgkin's lymphoma (LGNHL) has been described occasionally in the literature with the potential pathogenetic role of monoclonal B CD5+/CD19+ cells. We report a case of LGNHL which developed 18 months after diagnosis of SLE. The monoclonal population of lymphocytes in the peripheral blood and bone marrow was CD5/CD19 negative but CD19/CD22 positive. The SLE responded well to treatment with prednisone and the course of the LGNHL was stable and cytotoxic treatment was not required.